http://reports.oah.state.nc.us/ncac/title%2010a%20-%20health%20and%20human%20services/chapter%2013%20-%20nc%20medical%20care%20commission/subchapter%20g/subchapter%20g%20rules.pdf WebJan 30, 2024 · Below is a list of state regulations regarding Medication Aides. The list is not all inclusive. Please contact the DHSR Nursing Home Licensure Section or the North Carolina Board of Nursing regarding the role of Medication Aides in long-term care facilities. •N.C. § 131E-114.2(b) •N.C. § 131E-256 •N.C. § 131E-270 •N.C. § 90-171.56
Compendium of Residential Care and Assisted Living …
WebApr 14, 2024 · State-approved Nurse Aide I competency evaluation meets the requirements of federal regulations [42 CFR 483, Subpart B 483.75 (e) ; Subpart D 483.150-158 ]. "Competency evaluation", when used in conjunction with Medication Aide, refers to state-approved testing that measures medication aide-related knowledge, skills, and abilities. Webquarterly each resident’s medications and the facility’s medication policies and procedures, or more frequently as required by the Department based on documentation of specific medication problems in the facility. ACHs must ensure that training on the care of residents with diabetes is provided b_damiano
N.C. Medication Aide Registry for Adult Care Homes
Webmedication. 5. Staff/Resident/Person accompanying resident check to ensure sufficient 2. Read all directions carefully. 6. Discuss facility policy and procedure for return of unused … Web(37) "License" means a permit to operate a facility which is issued by DHSR under G.S. 122C, Article 2. (38) "Medication" means a substance recognized in the official "United States Pharmacopoeia" or "National Formulary" intended for use in the diagnosis, mitigation, treatment or prevention of disease. Web(4) approval by the Adult Care Licensure Section of the facility's operational policies and procedures based on compliance with the rules of this Subchapter; and (5) the facility's demonstration of compliance with Adult Care Home statutes and rules of this Subchapter ba 4/5次世代疫苗